Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)
32.61
+0.30 (0.93%)
Oct 23, 2026, 3:00 PM CST
SHA:603139 Market Cap
SHA:603139 has a market cap or net worth of 3.26 billion as of October 23, 2026. It is the 14,685th most valuable company in the world and the 3,961st biggest in China. Its market cap has increased by 46.23% in one year.
Market Cap
3.26B
Enterprise Value
3.97B
Revenue
429.09M
Global Rank
Country Rank
#3,961 China
PE Ratio
n/a
ChartMarket Cap Chart
Since April 21, 2017, SHA:603139's market cap has increased from 2.10B to 3.26B, an increase of 55.43%. That is a compound annual growth rate of 4.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.26B | 59.31% |
| Dec 31, 2025 | 2.04B | 42.55% |
| Dec 31, 2024 | 1.43B | -23.49% |
| Dec 29, 2023 | 1.87B | 5.75% |
| Dec 30, 2022 | 1.77B | -18.47% |
| Dec 31, 2021 | 2.17B | 29.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Neptunus Bioengineering | 3.45B |
| PKU HealthCare Corp.,Ltd. | 3.40B |
| ChengDu ShengNuo Biotec | 3.35B |
| Harbin Medisan Pharmaceutical | 3.24B |
| Qianjiang Yongan Pharmaceutical | 3.23B |
| Huaren Pharmaceutical | 3.23B |
| Shanghai MicuRx Pharmaceutical | 3.21B |
| Nanjing Hicin Pharmaceutical | 3.21B |